Dent, S F <br/><br/>
Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancer.  [electronic resource] 

 -  Lung   
 - 265-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0341-2040 
<br/><br/><label>Standard No.: </label>10.1007/s00408-004-2539-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cytosine--administration & dosage<br/>Dioxolanes--administration & dosage<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged